Long non-coding RNA screening and identification of a potential biomarker for type 2 diabetes. Long non-coding RNA screening and identification of a potential biomarker for type 2 diabetes

Improving the early diagnosis and treatment of type 2 diabetes (T2D) can effectively control blood glucose. To investigate new long non-coding RNAs (lncRNAs) as molecular markers we used microarrays to identify differentially expressed lncRNAs and mRNAs in peripheral blood mononuclear cells from T2D patients and controls. Overall design: RNA samples from five patients with T2D and five healthy controls. Each sample was tested five times.